Mei, C.; Zhang, X.; Zhi, Y.; Liang, Z.; Xu, H.; Liu, Z.; Liu, Y.; Lyu, Y.; Wang, H.
Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors. Int. J. Mol. Sci. 2024, 25, 670.
https://doi.org/10.3390/ijms25010670
AMA Style
Mei C, Zhang X, Zhi Y, Liang Z, Xu H, Liu Z, Liu Y, Lyu Y, Wang H.
Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors. International Journal of Molecular Sciences. 2024; 25(1):670.
https://doi.org/10.3390/ijms25010670
Chicago/Turabian Style
Mei, Chen, Xue Zhang, Yan Zhi, Zhixuan Liang, Haojun Xu, Zhenyi Liu, Ying Liu, Yanli Lyu, and Hongjun Wang.
2024. "Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors" International Journal of Molecular Sciences 25, no. 1: 670.
https://doi.org/10.3390/ijms25010670
APA Style
Mei, C., Zhang, X., Zhi, Y., Liang, Z., Xu, H., Liu, Z., Liu, Y., Lyu, Y., & Wang, H.
(2024). Isorhamnetin Regulates Programmed Death Ligand-1 Expression by Suppressing the EGFR–STAT3 Signaling Pathway in Canine Mammary Tumors. International Journal of Molecular Sciences, 25(1), 670.
https://doi.org/10.3390/ijms25010670